PRINCETON, NJ -- (MARKET WIRE) -- May 30, 2007 -- Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that Dr. Geert Cauwenbergh, Chief Executive Officer, will participate in the FTN Midwest Health Care Conference.
